Metabolomics through the lens of precision cardiovascular medicine

J Genet Genomics. 2017 Mar 20;44(3):127-138. doi: 10.1016/j.jgg.2017.02.004. Epub 2017 Mar 8.


Metabolomics, which targets at the extensive characterization and quantitation of global metabolites from both endogenous and exogenous sources, has emerged as a novel technological avenue to advance the field of precision medicine principally driven by genomics-oriented approaches. In particular, metabolomics has revealed the cardinal roles that the environment exerts in driving the progression of major diseases threatening public health. Herein, the existent and potential applications of metabolomics in two key areas of precision cardiovascular medicine will be critically discussed: 1) the use of metabolomics in unveiling novel disease biomarkers and pathological pathways; 2) the contribution of metabolomics in cardiovascular drug development. Major issues concerning the statistical handling of big data generated by metabolomics, as well as its interpretation, will be briefly addressed. Finally, the need for integration of various omics branches and adopting a multi-omics approach to precision medicine will be discussed.

Keywords: Cardiovascular diseases; Lipidomics; Metabolomics; Multi-omics; Precision medicine.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism*
  • Humans
  • Metabolomics / methods*
  • Precision Medicine / methods*


  • Biomarkers